Operates 94 global pharmaceutical company to develop 176 kinds of weight loss capsules, these companies are racing to reach the capsule safe and effective way to achieve this end.
This comes after the spread of obesity dramatically in a world where suffering in the United States alone, 44 million people (60 million according to other estimates).
They spent last year alone on medicines and lotions and anti-obesity exercises $ 41 billion, and they realize the gravity and are ready to pay any price to get rid of them.
In 1991, The University of Florida in the United States a questionnaire to forty-seven people from obese patients, most of them said that he would prefer to become blind or deaf to grow and weighed more than it is.
In a recent survey conducted in the United States, offered to schoolchildren pictures of children with disabilities (paralyzed or not moving only Bekazat, or amputees hands) and then offered them also the image of a child obese, students chose obese child's image as the worst of these images and the most hatred.
When such a culture prevails, it is natural that the drug companies are racing to produce drugs to lose weight, to the extent that the magazine "Business 2" interested in the world of business and finance has devoted a lengthy report in last month dealing with the economics of this race.
And most of the drug companies seeking to develop antagonists or inhibitors of hunger, and follow each company a path or a different approach from other companies, also revealing what you up from the results.
cam Pfizer, for example, spent millions to draw "anti-hunger" is a mixture of cactuses and saliva an panyAfrican monkeys, but the project was amended to ineffective, and still looking for other methods.
The researchers Eli Lilly company to work on the hormone to regulate appetite, so as to control the so-called "hunger hormone" (Gerelan). The more of this hormone in the blood as human hair hungry.
While working companies such as Riggnieron and the French Sanofi drug development work by disabling neurological brain receptors responsible for the raising of appetite, Amgen Inc. spent $ 20 million for a license to exploit the discovery of the hormone gives the feeling of satiety.
ى
The company GlaxoSmithKline is working on the development of medicine is radically different from other drugs, it is not an anti-hunger, but working on "Burn" excess carbohydrates before they reach the liver and turn into fat.
With multiple attempts in this regard, the initial tests on some of them proved to have side effects, but the companies continue to minimize the development of drug until it gets a license from the Food and Drug Administration.
This race may take 5 to 10 years, but it certainly will not one company, the nature of the human body to fight hunger on more than one level amenable to comply with a single drug.
Experts believe that it will end with the patient to use a combination of drugs, each of which deals with a human body tricks to resist hunger. Also some hope that decoded the human genetic genome will enable doctors to determine the cause of one or a major obesity with each patient, and then draw a single drug for the treatment of that reason.
إرسال تعليق